Both the atherosclerosis markers ie mean ICAM-1 and Lp(a) were significantly higher in the NAFLD group compared to the non-NAFLD group (334.53±72.86 vs 265.46 ±102.92 ng/mL, p = 0.001, 85.41±52.56 vs 23.55±23.66 nmol/L, p <0.001, respectively). This evidence concerns the gene LPA and metabolic dysfunction-associated steatotic liver disease.